Proton-pump inhibitors among adults: a nationwide drug-utilization study ...

Background:The use of proton-pump inhibitors (PPIs) has grown worldwide, and there are concerns about increased unsubstantiated long-term use. The aim of the study was to describe the real-world use of PPIs over the past decade in an entire national population.Methods:This was a nationwide populatio...

Full description

Bibliographic Details
Main Authors: Hálfdánarson, Óskar Ö., Pottegård, Anton, Björnsson, Einar S., Lund, Sigrún H., Ogmundsdottir, Margret H., Steingrímsson, Eiríkur, Ogmundsdottir, Helga M., Zoega, Helga
Format: Article in Journal/Newspaper
Language:unknown
Published: Figshare 2018
Subjects:
Online Access:https://dx.doi.org/10.25384/sage.c.4118006.v1
https://figshare.com/collections/Proton-pump_inhibitors_among_adults_a_nationwide_drug-utilization_study/4118006/1
Description
Summary:Background:The use of proton-pump inhibitors (PPIs) has grown worldwide, and there are concerns about increased unsubstantiated long-term use. The aim of the study was to describe the real-world use of PPIs over the past decade in an entire national population.Methods:This was a nationwide population-based drug-utilization study. Patterns of outpatient PPI use among adults in Iceland between 2003 and 2015 were investigated, including annual incidence and prevalence, duration of use, and dose of tablet used (lower versus higher), as well as the proportion of PPI use attributable to gastroprotection.Results:We observed 1,372,790 prescription fills over the entire study period, of which 95% were for higher-dose PPIs. Annual incidence remained stable across time (3.3–4.1 per 100 persons per year), while the annual prevalence increased from 8.5 per 100 persons to 15.5 per 100 persons. Prevalence increased with patient age and was higher among women than men. Duration of treatment increased with patients’ age (36% ...